Petra Dinjar Kujundzic

Hepatologist, University Hospital Dubrava, Croatia

[Thomas Reiberger @ReibergerThomas]

Baveno VIII Consensus Conference provides updated guidance on advanced chronic liver disease, portal hypertension and vascular liver disease

https://t.co/2krDpahTm3

[Petra Dinjar Kujundzic @PDinjar1]

PH usually resolves after LTx- but not always.
Persistent thrombocytopenia (<110 G/L) at 3 months may serve as a simple marker for post-Tx risk stratification.

https://t.co/8k3fXmrlVr

#LiverTransplantation #PortalHypertension

[Mattias Mandorfer @MattiasMandorf1]

Bavevo VIII is online @JHepatology

🙏 to my panel co-chair @docberza & panellists @JuanAbraldes @EltonDajti @mathiasjachs @VWSWong et al

#LiverTwitter

Time for another @EASLedu Talk Liver To Me Episode, @tom_marjot ?

[Liver Transplantation Journal (LTxJournal) @LTxJournal]

In a retrospective study, post-LT VITRO dynamics independently predicted mortality and portal hypertension-related events. Failure to normalize may identify patients at risk.

@ReibergerThomas @PDinjar1 @balcar_lorenz @BenediktHofer @MattiasMandorf1

https://t.co/XxeZKGNCyY

[Thomas Reiberger @ReibergerThomas]

🚨@BavenoCoop VIII consensus document

#PortalHypertension #Cirrhosis #PSVD
2⃣7⃣2⃣ recommendations for clinical practice
1⃣5⃣3⃣ research priority topics

🎓thx to Baveno VIII faculty & all supporters
🧨soon in @JHepatology - 🍿stay tuned !!

[Thomas Reiberger @ReibergerThomas]

👏Drs. Thöne @mathiasjachs & @MattiasMandorf1 of @MedUni_Wien @ViennaLiverNews @CrgMotion

➡️ spleen stiffness (#SSM) non-invasively predict #portalpressure response to betabockers
⚙️ #SSM change 📉 = surrogates in clinical trials

🔗@LiverInt article: https://t.co/omBL8d3VXn

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

New @TheLancet - Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study

https://t.co/iTad0qLeje

#LiverTwitter #MedTwitter @Liver_Screen

[Thomas Reiberger @ReibergerThomas]

Bleeding after #Endoscopic banding of #Varices (#EBL #EVL) from ulcers (#PBUB).

more commen after #emergency procedures and in patients with #renal #dysfunction

@AP&T 2026
https://t.co/FhSGzgnacI

[Thomas Reiberger @ReibergerThomas]

#Liver #Cirrhosis
1⃣ Machine Learning for #PortalHypertension diagnosis using only 3 or 5 routine blood 🩸parameters 🔗https://t.co/lgd0NT1d65
2⃣ 3P/5P #MLM predict #PH in #HepatitisD 🔗https://t.co/R1MEQ6upXi
3⃣ 3P/5P #MLM predict #Decompensation
🔗https://t.co/9enmILaqJO

[Mattias Mandorfer @MattiasMandorf1]

Multi-society expert panel consensus guidance on definition & management of alpha-1 antitrypsin deficiency-associated liver disease (AATD-LD)

#LiverTwitter

In press @AGA_Gastro
🖇️ https://t.co/auQtsnsBKZ

[Thomas Reiberger @ReibergerThomas]

#LiverX
Prevalence of #Steatosis and #Fibrosis in🇦🇹#Austria by🩸blood-based and #Elastography 🔊based non-invasive tests (#NITs)

📕full study @AGA_CGH
https://t.co/hlrNsO9ncM

[Mark Parisi 🦀 @OffTheMarkComic]

That's how they getcha

[Petra Dinjar Kujundzic @PDinjar1]

@IvaKosuta @docMPK @RoyAHep @drnipunverma @AnandVKulkarni2 This year I’ve seen several ALF cases: HBV reactivation 14mo after rituximab-based chemo (no prophylaxis 😔), WD, mushrooms and recently a fatal ALF after immunoth for metastatic melanoma. Not rare, but never easy

[Petra Dinjar Kujundzic @PDinjar1]

Prof. Berzigotti provided an excellent overview of current evidence and an clear introduction to the forthcoming #BavenoVIII Consensus @BavenoCoop during the Hepatology Symposium in Berlin #FalkFoundation

[LiverUnit_VallHebron @LHuvh]

The 25 kPa for #CSPH is valid, buy the #ANTICIPATE+/- NASH 75% is better. A new ruling in criterion for CSPH by the @BavenoCoop:
Refining the Baveno VII criteria for clinically significant portal hypertension- Journal of Hepatology
https://t.co/kVn8h8oB1r
@LHuvh @VHIR_ @ciberehd

[JHEP Reports @JHEP_Reports]

🟣Relative exchangeable copper: A highly specific and sensitive biomarker for Wilson disease diagnosis

🔓#OpenAccess at👉https://t.co/aA6K8uxkXo

#LiverTwitter #LiverX #WilsonDisease

[Sebastian Niezen MD, MSc @sniezenMD]

Cannot express how much this has helped me throughout the start of Fellowship #Livertwitter
@BIDMC_GI

[Thomas Reiberger @ReibergerThomas]

🇦🇹Vienna🩸Blood-based 3P/5P risk models accurately predict #liver related complications in pts with #cirrhosis

📕Study in @JHEP_Reports https://t.co/ItQDRdN38G

Initially developed for #PortalHypertension Evaluation
@JHepatology 🔗 https://t.co/13lziJLj6Q

[Petra Dinjar Kujundzic @PDinjar1]

@IvaKosuta CROlonization 🤩 top

[Iva Košuta @IvaKosuta]

In cirrhosis, mortality in the ICU was driven by organ failure, not infection — showing the need to act earlier. Colonization didn’t predict infection, but when infection occurred, it often matched the colonizing strain. https://t.co/AyW2AzVTRn